Exosome Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global exosome market looks promising with opportunities in academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinical testing laboratories. The global exosome market is expected to grow with a CAGR of 23%-25% from 2020 to 2025. The major drivers for this market are increasing funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome based procedures.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global exosome market report, please download the report brochure.
In this market, kits and reagents is the largest product and service type of exosome, whereas academic and research institutes is the largest end user. Growth in various segments of the exosome market are given below:
The study includes trends and forecast for the global exosome market by product and service, application, end user, workflow, bimolecule type, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that kits and reagents will remain the largest product & service segment over the forecast period due to the increasing demand for liquid biopsy tests, increasing basic research and commercial applications of exosome, and the need for reliable and specific diagnostic assays.
Within this market, academic & research institutes will remain the largest end user segment over the forecast period due to the growing use of exosome in cancer and stem cell research and increasing number of cancer & stem cell research projects across the globe.
North America will remain the largest region over the forecast period due to availability of government funding for life sciences research, favorable regulatory environment, increasing focus on exosome in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research.
Features of the Global Exosome Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global exosome market by product & service (kits and reagents, instruments, and services), application (cancer applications (lung cancer, breast cancer, prostate cancer, colorectal cancer, and other cancers) and non-cancer applications), end user (academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinical testing laboratories), workflow (isolation methods (ultracentrifugation, immunocapture on beads, precipitation, and filtration) and downstream analysis (cell surface marker analysis using flow cytometry, protein analysis using blotting & ELISA, RNA analysis with NGS & PCR, proteomic analysis using mass spectrometry, and others), biomolecule type (non-coding RNAs, mRNA, proteins/peptides, DNA fragments, and lipids), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global exosome market?
Q.5 What are the business risks and threats to the global exosome market?
Q.6 What are the emerging trends in this exosome market and the reasons behind them?
Q.7 What are some changing demands of customers in this exosome market?
Q.8 What are the new developments in this exosome market? Which companies are leading these developments?
Q.9 Who are the major players in this exosome market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this exosome market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global exosome market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Service (Kits and Reagents, Instruments, and Services), Application (Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories), Workflow (Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others), and Biomolecule Type (Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids)
Regional Scope North America (USA, Mexico, and Canada), Europe (Germany, United Kingdom, Spain, Italy, and France), Asia (China, Japan, and India), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global exosome market looks promising with opportunities in academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinical testing laboratories. The global exosome market is expected to grow with a CAGR of 23%-25% from 2020 to 2025. The major drivers for this market are increasing funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome based procedures.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global exosome market report, please download the report brochure.
In this market, kits and reagents is the largest product and service type of exosome, whereas academic and research institutes is the largest end user. Growth in various segments of the exosome market are given below:
The study includes trends and forecast for the global exosome market by product and service, application, end user, workflow, bimolecule type, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
- Kits and Reagents
- Instruments
- Services
- Cancer Applications
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Other Cancers
- Non-Cancer Applications
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinical Testing Laboratories
- Isolation Methods
- Ultracentrifugation
- Immunocapture on Beads
- Precipitation
- Filtration
- Downstream Analysis
- Cell Surface Marker Analysis Using Flow Cytometry
- Protein Analysis Using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis Using Mass Spectrometry
- Others
- Non-Boding RNAs
- mRNA
- Proteins /Peptides
- DNA Fragments
- Lipids
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- Spain
- Italy
- France
- Asia Pacific
- China
- Japan
- India
- The Rest of the World
- Brazil
Lucintel forecasts that kits and reagents will remain the largest product & service segment over the forecast period due to the increasing demand for liquid biopsy tests, increasing basic research and commercial applications of exosome, and the need for reliable and specific diagnostic assays.
Within this market, academic & research institutes will remain the largest end user segment over the forecast period due to the growing use of exosome in cancer and stem cell research and increasing number of cancer & stem cell research projects across the globe.
North America will remain the largest region over the forecast period due to availability of government funding for life sciences research, favorable regulatory environment, increasing focus on exosome in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research.
Features of the Global Exosome Market
- Market Size Estimates: Global exosome market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global exosome market size by various segments, such as product and service, application, end user, workflow, and bimolecule type in terms of value.
- Regional Analysis: Global exosome market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product and service, application, end user, workflow, bimolecule type, and region for the global exosome market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global exosome market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global exosome market by product & service (kits and reagents, instruments, and services), application (cancer applications (lung cancer, breast cancer, prostate cancer, colorectal cancer, and other cancers) and non-cancer applications), end user (academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinical testing laboratories), workflow (isolation methods (ultracentrifugation, immunocapture on beads, precipitation, and filtration) and downstream analysis (cell surface marker analysis using flow cytometry, protein analysis using blotting & ELISA, RNA analysis with NGS & PCR, proteomic analysis using mass spectrometry, and others), biomolecule type (non-coding RNAs, mRNA, proteins/peptides, DNA fragments, and lipids), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global exosome market?
Q.5 What are the business risks and threats to the global exosome market?
Q.6 What are the emerging trends in this exosome market and the reasons behind them?
Q.7 What are some changing demands of customers in this exosome market?
Q.8 What are the new developments in this exosome market? Which companies are leading these developments?
Q.9 Who are the major players in this exosome market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this exosome market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global exosome market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Service (Kits and Reagents, Instruments, and Services), Application (Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories), Workflow (Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others), and Biomolecule Type (Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids)
Regional Scope North America (USA, Mexico, and Canada), Europe (Germany, United Kingdom, Spain, Italy, and France), Asia (China, Japan, and India), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Exosome Market Trends and Forecast
3.3: Global Exosome Market by Product & Service
3.3.1: Kits & Reagents
3.3.2: Instruments
3.3.3: Services
3.4: Global Exosome Market by Application
3.4.1: Cancer Applications
3.4.1.1: Lung Cancer
3.4.1.2: Breast Cancer
3.4.1.3: Prostate Cancer
3.4.1.4: Colorectal Cancer
3.4.1.5: Other Cancers
3.4.2: Non-Cancer Applications
3.5: Global Exosome Market by End User
3.5.1: Academic & Research Institutes
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Hospitals & Clinical Testing Laboratories
3.6: Global Exosome Market by Workflow
3.6.1: Isolation Methods
3.6.1.1: Ultracentrifugation
3.6.1.2: Immunocapture on beads
3.6.1.3: Precipitation
3.6.1.4: Filtration
3.6.2: Downstream Analysis
3.6.2.1: Cell Surface Marker Analysis using Flow Cytometry
3.6.2.2: Protein Analysis using Blotting & ELISA
3.6.2.3: RNA Analysis with NGS & PCR
3.6.2.4: Proteomic Analysis using Mass Spectrometry
3.6.2.5: Others
3.7: Global Exosome Market by Biomolecule Type
3.7.1: Non-Coding RNAs
3.7.2: mRNA
3.7.3: Proteins/Peptides
3.7.4: DNA Fragments
3.7.5: Lipids
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Exosome Market by Region
4.2: North American Exosome Market
4.2.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.2.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.2.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.2.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.2.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.2.6: The United States Exosome Market
4.2.7: The Canadian Exosome Market
4.2.8: The Mexican Exosome Market
4.3: European Exosome Market
4.3.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.3.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.3.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.3.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.3.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.3.6: The German Exosome Market
4.3.7: The United Kingdom Exosome Market
4.3.8: The Spain Exosome Market
4.3.9: The Italy Exosome Market
4.3.10: The French Exosome Market
4.4: APAC Exosome Market
4.4.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.4.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.4.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.4.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.4.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.4.6: The Chinese Exosome Market
4.4.7: The Indian Exosome Market
4.4.8: The Japanese Exosome Market
4.5: ROW Exosome Market
4.5.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.5.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.5.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.5.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.5.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.5.5: Brazilian Exosome Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Exosome Market by Product & Service
7.1.2: Growth Opportunities for the Global Exosome Market by Application
7.1.3: Growth Opportunities for the Global Exosome Market by End User
7.1.4: Growth Opportunities for the Global Exosome Market by Workflow
7.1.5: Growth Opportunities for the Global Exosome Market by Biomolecule Type
7.1.6: Growth Opportunities for the Global Exosome Market by Region
7.2: Emerging Trends in the Global Exosome Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Exosome Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific Inc.
8.2: QIAGEN N.V.
8.3: Bio-Techne
8.4: Company
8.5: Company
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Exosome Market Trends and Forecast
3.3: Global Exosome Market by Product & Service
3.3.1: Kits & Reagents
3.3.2: Instruments
3.3.3: Services
3.4: Global Exosome Market by Application
3.4.1: Cancer Applications
3.4.1.1: Lung Cancer
3.4.1.2: Breast Cancer
3.4.1.3: Prostate Cancer
3.4.1.4: Colorectal Cancer
3.4.1.5: Other Cancers
3.4.2: Non-Cancer Applications
3.5: Global Exosome Market by End User
3.5.1: Academic & Research Institutes
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Hospitals & Clinical Testing Laboratories
3.6: Global Exosome Market by Workflow
3.6.1: Isolation Methods
3.6.1.1: Ultracentrifugation
3.6.1.2: Immunocapture on beads
3.6.1.3: Precipitation
3.6.1.4: Filtration
3.6.2: Downstream Analysis
3.6.2.1: Cell Surface Marker Analysis using Flow Cytometry
3.6.2.2: Protein Analysis using Blotting & ELISA
3.6.2.3: RNA Analysis with NGS & PCR
3.6.2.4: Proteomic Analysis using Mass Spectrometry
3.6.2.5: Others
3.7: Global Exosome Market by Biomolecule Type
3.7.1: Non-Coding RNAs
3.7.2: mRNA
3.7.3: Proteins/Peptides
3.7.4: DNA Fragments
3.7.5: Lipids
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Exosome Market by Region
4.2: North American Exosome Market
4.2.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.2.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.2.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.2.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.2.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.2.6: The United States Exosome Market
4.2.7: The Canadian Exosome Market
4.2.8: The Mexican Exosome Market
4.3: European Exosome Market
4.3.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.3.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.3.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.3.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.3.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.3.6: The German Exosome Market
4.3.7: The United Kingdom Exosome Market
4.3.8: The Spain Exosome Market
4.3.9: The Italy Exosome Market
4.3.10: The French Exosome Market
4.4: APAC Exosome Market
4.4.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.4.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.4.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.4.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.4.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.4.6: The Chinese Exosome Market
4.4.7: The Indian Exosome Market
4.4.8: The Japanese Exosome Market
4.5: ROW Exosome Market
4.5.1: Market by Product & Service: Kits and Reagents, Instruments, and Services
4.5.2: Market by Application: Cancer Applications (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, and Other Cancers) and Non-Cancer Applications
4.5.3: Market by End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Clinical Testing Laboratories
4.5.4: Market by Workflow: Isolation Methods (Ultracentrifugation, Immunocapture on beads, Precipitation, and Filtration) and Downstream Analysis (Cell Surface Marker Analysis using Flow Cytometry, Protein Analysis using Blotting & ELISA, RNA Analysis with NGS & PCR, Proteomic Analysis using Mass Spectrometry, and Others
4.5.5: Market by Biomolecule Type: Non-Coding RNAs, mRNA, Proteins/Peptides, DNA Fragments, and Lipids
4.5.5: Brazilian Exosome Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Exosome Market by Product & Service
7.1.2: Growth Opportunities for the Global Exosome Market by Application
7.1.3: Growth Opportunities for the Global Exosome Market by End User
7.1.4: Growth Opportunities for the Global Exosome Market by Workflow
7.1.5: Growth Opportunities for the Global Exosome Market by Biomolecule Type
7.1.6: Growth Opportunities for the Global Exosome Market by Region
7.2: Emerging Trends in the Global Exosome Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Exosome Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific Inc.
8.2: QIAGEN N.V.
8.3: Bio-Techne
8.4: Company
8.5: Company
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
